As enthusiasm around psychedelics and their possible benefits continues to grow, it’s imperative that researchers, user populations, and clinicians look closely at HPPD and other possible hazards.

Psychedelics and Self-Treatment

May 20, 2023 Lynne Nardizzi

This study investigated the patterns of use, self-reported outcomes and outcome predictors of psychedelic ‘self-treatment’ of mental health conditions or specific worries/concerns in life.

Positive changes were observed across all 17 outcome items, with the strongest benefits on items related to insight and mood.

Psilocybin and Lyme Disease?

May 19, 2023 Lynne Nardizzi

Psilocybin is both serotonergic and anti-inflammatory and therefore may offer significant therapeutic benefits to patients with mental illness secondary to autoimmune inflammation.

This study suggests that the role of microdosed psilocybin in the treatment of neuropsychiatric Lyme disease and autoimmune encephalopathies warrants further study.

LSD, Psychosis and Healing

May 18, 2023 Lynne Nardizzi

This study explores the paradoxical relationship connecting key parameters of the psychotic experience, psychotherapy, and psychedelic experience.

The link between psychosis model and therapeutic model seems to lie in mystical experiences.

The results point to the importance of meaning attribution for the LSD psychosis model and indicate that psychedelic-assisted therapy might benefit from therapeutic suggestions fostering mystical experiences.

Blog

Guides are shouldering the expectations generated by massive hype, but are underpaid, under-celebrated, sometimes exploited, and inexperienced.